Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Hybrid/Virtual/Decentralized Clinical Trials Market Report 2021 with a Survey of Sponsors and CROs


DUBLIN, Aug. 4, 2021 /PRNewswire/ -- The "Hybrid/Virtual/Decentralized Clinical Trials Market Outlook" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Change is hard and it can certainly be intimidating, especially in an area like drug development when there is much at stake and many complexities to manage.

Enter COVID-19.

The industry had no choice but to adapt to maintain any sort of momentum on clinical development activities. The hybrid model quickly became essential for allowing patients to continue with their trials amidst a global pandemic and the myriad health and logistical concerns that accompanied it.

The publisher surveyed 109 respondents at sponsors and CROs regarding their experiences with hybrid trials and providers of these services. Though not all reported a smooth, pain-free experience, nearly two-thirds of respondents came away with a positive overall impression of hybrid trials.

Furthermore, respondents do not seem to consider the hybrid trial model as a temporary solution to be discarded after the pandemic has subsided. 83% of respondents expect that the hybrid trial model will be used more frequently than the traditional trial model three years from now. These data are saying loud and clear that hybrid trials are here to stay.

What You Will Learn:

Pharmaceutical Organizations:

Service Providers:

Major Topics:

Key Topics Covered:

1. Hybrid Trial Use and Experience

2. Provider Selection

3. Provider Perceptions

4. Future Predictions

5. Study Data

6. Demographics

For more information about this report visit https://www.researchandmarkets.com/r/dlmjoz

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...



News published on and distributed by: